News EPFL - EPFL

Using the matrix to help Meta gear up

Published:09.05.22 — Just 12 months after it was created, in December 2004, 1 million people were active on Facebook. As of December 2021 it had an average 1.93 billion daily active users. EPFL is in a unique collaboration with its parent company Meta around distributed deep learning research.

The role of surface tension in biological symmetry

Published:06.05.22 — EPFL researchers have discovered that symmetry in the vertebrate body is influenced by surface tension, the same mechanical phenomenon that allows lightweight insects to walk on water. A paper discussing this surprising finding, which is akin to a form of natural self-correction, has been published in the journal Nature.

Single photon emitter takes a step closer to quantum tech

Published:05.05.22 — To get closer to quantum technology we need to develop non-classical light sources that can emit a single photon at a time and do so on demand. Scientists at EPFL have now designed one of these “single photon emitters” that can work at room temperature and are based on quantum dots grown on cost-effective silicon substrates.

Imaging chemical kinetics at liquid-liquid interfaces

Published:04.05.22 — Scientists led by EPFL have developed a new method to measure chemical kinetics by imaging progress of a reaction at a liquid-liquid interface embedded in a laminar-flow liquid microjet. This method is ideal for studies of dynamics on the sub-millisecond timescale, which is very difficult to do with current applications.

A solution to perovskite solar cell scalability problems

Published:03.05.22 — Scientists at EPFL have found a way to overcome power loss and the manufacturing complexity of scaling up perovskite solar cells.

When the animal world inspires science

Published:02.05.22 — From 29 April to 8 May 2022, EPFL will offer the public the chance to discover the close links between science and the animal world during the BEA fair in Bern.

A new mutation behind synucleinopathies

Published:29.04.22 — Scientists at EPFL have carried out an extensive study of a newly discovered mutation that can uncover new insights into the molecular basis of pathology formation in a family of disorders that includes Lewy body dementia and Parkinson’s disease.